SHILPAMEDUpdated 1 Sept 2026, 11:27

Shilpa Medicare Ltd

SHILPAMEDUpdated 1 Sept 2026, 11:27

Market Cap

₹17,594Cr.

Current Price

₹900

High / Low

₹951/260

Stock P/E

112

ROE3.88%

ROCE4.79%

Book Value₹139

Face Value₹1.00

Dividend Yield0.06%

About

Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company’s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML’s wholly owned subsidiary Shilpa Therapeutics.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	45	60	83	107	100	103	310	105	165	170	136	136
Inventory Days	142	126	173	174	275	283	1,847	472	420	458	450	285
Days Payable	77	99	103	103	111	105	351	111	142	215	121	138
Cash Conversion Cycle	110	87	153	179	264	281	1,806	466	443	412	464	283
Working Capital Days	37	33	83	103	110	235	271	135	573	188	172	146
ROCE %	21%	21%	16%	12%	11%	15%	2%	1%	-1%	3%	6%	5%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 11:27

SHILPA MEDICARE LTD (SHILPAMED) financials — quarterly results, P&L, cash flow, balance sheet, shareholding